| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Zhang, Le |
| dc.contributor.author | Yao, Honghui |
| dc.contributor.author | Jendle, Johan |
| dc.contributor.author | Ribases Haro, Marta |
| dc.contributor.author | Garcia-Argibay, Miguel |
| dc.contributor.author | Li, Lin |
| dc.contributor.author | Du Rietz, Ebba |
| dc.contributor.author | Ramos-Quiroga, Josep Antoni |
| dc.date.accessioned | 2023-02-23T13:08:12Z |
| dc.date.available | 2023-02-23T13:08:12Z |
| dc.date.issued | 2023-04 |
| dc.identifier.citation | Garcia-Argibay M, Li L, Du Rietz E, Zhang L, Yao H, Jendle J, et al. The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study. Neurosci Biobehav Rev. 2023 Apr;147:105076. |
| dc.identifier.issn | 0149-7634 |
| dc.identifier.uri | https://hdl.handle.net/11351/9044 |
| dc.description | Attention deficit hyperactivity disorder; Cardiovascular risk factors; Type 2 diabetes |
| dc.description.abstract | We conducted a systematic review and a meta-analysis to quantitatively summarize evidence on the association between attention-deficit/hyperactivity disorder (ADHD) and type 2 diabetes (T2D). Moreover, a register-based sibling study was conducted to simultaneously control for confounding factors. A systematic search identified four eligible observational studies (N = 5738,287). The meta-analysis showed that individuals with ADHD have a more than doubled risk of T2D when considering adjusted estimates (OR=2.29 [1.48–3.55], d=0.46). Results from the register-based Swedish data showed a significant association between ADHD and T2D (HR=2.35 [2.14–2.58]), with substance use disorder, depression, and anxiety being the main drivers of the association, and cardiovascular and familiar risk playing a smaller role. While results from the meta-analysis provide evidence for an increased risk of T2D in individuals with ADHD, the register-based analyses show that the association between ADHD and T2D is largely explained by psychiatric comorbidities. Pending further evidence of causal association, our findings suggest that early identification and treatment of ADHD comorbidities might greatly reduce the risk of developing T2D in individuals with ADHD. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Neuroscience & Biobehavioral Reviews;147 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Malalties - Factors de risc |
| dc.subject | Diabetis no-insulinodependent - Epidemiologia |
| dc.subject | Trastorn per dèficit d'atenció amb hiperactivitat - Epidemiologia |
| dc.subject.mesh | Diabetes Mellitus, Type 2 |
| dc.subject.mesh | Attention Deficit Disorder with Hyperactivity |
| dc.subject.mesh | Risk Factors |
| dc.subject.mesh | /epidemiology |
| dc.title | The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.neubiorev.2023.105076 |
| dc.subject.decs | diabetes mellitus tipo II |
| dc.subject.decs | trastornos de déficit de atención con hiperactividad |
| dc.subject.decs | factores de riesgo |
| dc.subject.decs | /epidemiología |
| dc.relation.publishversion | https://doi.org/10.1016/j.neubiorev.2023.105076 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Garcia-Argibay M, Li L] School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [Du Rietz E, Zhang L, Yao H] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [Jendle J] School of Medical Sciences, Örebro University, Faculty of Medicine and Health, Örebro, Sweden. [Ramos-Quiroga JA] Departament de Psiquiatria i Medicina Forense, Universitat Autònoma de Barcelona, Bellaterra, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain. Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Unitat de Genètica Psiquiàtrica, Grup de Recerca de Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ribasés M] Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain. Servei de Psiquiatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Unitat de Genètica Psiquiàtrica, Grup de Recerca de Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 36754221 |
| dc.relation.projectid | info:eu-repo/grantAgreement/EC/H2020/965381 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |